Skip to content

Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma

Project ASPIRE: Improving Pediatric Asthma Management for Urban Families

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00384813
Acronym
ASPIRE
Enrollment
43
Registered
2006-10-06
Start date
2007-01-31
Completion date
2009-04-30
Last updated
2014-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Stress and anxiety can negatively affect children with asthma. Reducing the stress of asthmatic children and their families may lead to improved asthma care and fewer asthma symptoms in the children. The purpose of this study is to develop and evaluate a family-focused asthma education program aimed at reducing stress levels and improving asthma care for urban children with asthma.

Detailed description

Asthma is a serious, chronic illness that affects 9 million children in the United States. Common asthma symptoms include wheezing, shortness of breath, chest tightness, and coughing. Asthma attacks can be triggered by a variety of irritants, including mold, pollen, tobacco smoke, or allergies. Stress can also cause asthma attacks, and children who experience high levels of stress and anxiety tend to have poor asthma management skills and health outcomes. Additionally, family stress can affect the ability of families and caregivers to provide adequate care to children with asthma. Currently, few asthma education programs are aimed at helping both children and parents manage stress. The purpose of this study is to evaluate the effectiveness of a stress-reduction family intervention on improving health outcomes in asthmatic children. Study researchers will first conduct focus groups with children who have asthma, their parents, and community health organizations to identify barriers to effective asthma management and sources of stress for caregivers; a family-focused intervention will then be developed. Fifty families with an asthmatic child will be enrolled and randomly assigned to one of two groups. Group 1 participants will partake in four to six home-based, family educational sessions over a 4-month period. Sessions will focus on asthma education and stress management techniques for the entire family. One of these sessions may take place at the child's doctor's office as a way to focus on improving parent-doctor communication. Group 2 participants will partake in a single home-based asthma education session. Study visits for all participants will occur at baseline, Month 4, and 6 months post-intervention. At these timepoints, asthma self-management will be assessed through family interviews and observation of the child's inhaler use; tobacco exposure levels will be measured with a urine test; and family functioning and stress levels will be assessed with questionnaires.

Interventions

BEHAVIORALProject ASPIRE Home-Based Family Intervention

Home-based psychoeducational family intervention jointly conducted by psychology postdoctoral fellow and respiratory therapist over 4 months

BEHAVIORALProject ASPIRE Enhanced Treatment As Usual

Psychoeducational family intervention addressing the written asthma action plan during a single home visit, conducted by a respiratory therapist

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of persistent asthma * Poorly controlled asthma, as determined by emergency department visit, hospitalization, or steroid burst in the year prior to study entry * Primary caregiver is under stress, as determined by a significantly elevated score on measures of stress * Receives Medicaid or participates in Medicaid HMO * Resides in the Atlanta metropolitan area

Exclusion criteria

* Nonatopic, nonpsychiatric illness that requires daily medication * Diagnosis of asthma in the year prior to study entry * Homeless * Caregiver is unable to complete study screening process * Caregiver does not speak English

Design outcomes

Primary

MeasureTime frameDescription
Mean Score on the Family Asthma Management System Scale (FAMSS)4 months from baselineFamily Asthma Management System Scale is semi-structured clinical interview that includes open-ended questions assessing family management of pediatric asthma. The interview is recorded and rated using a standard manual on seven core subscales and two optional subscales.The interview is recorded and rated on seven to nine 9-point subscales that tap the various domains of asthma management, with higher scores indicating better management (1 being the worse asthma management and 9 being the best asthma management). Mean of all of the subscales used to compute a total score.
Metered Dose Inhaler Checklist (MDIC)4 months, 10 monthsObservational rating scale assessing MDI/spacer technique
Asthma Morbidity, as Determined by Number of Asthma Symptom Days, Number of School Days Missed Due to Asthma, and Number of Emergency Department Visits for Acute Asthma4 months, 10 months

Secondary

MeasureTime frame
Parenting Stress Index - SF (PSI-SF)4 months, 10 months
Brief Symptom Inventory (BSI)4 months, 10 months

Countries

United States

Participant flow

Recruitment details

Families were recruited from an urban hospital and a residential camp for children with asthma. Initial eligibility criteria : (a) residence in one of two urban counties, (b) child age 8 to 13, (c) Medicaid or State Children's Health Insurance Program, (d) current prescription of a daily controller agent, and (e) poorly controlled asthma.

Pre-assignment details

Caregivers of children meeting initial eligibility criteria were interviewed briefly by phone; those answering affirmatively to either of two stress questions were invited to participate in a Screening Assessment. Caregivers with an elevated score on a stress measure were invited to participate in the trial.

Participants by arm

ArmCount
1: Home-based Family Intervention
Home-based family intervention Project ASPIRE Home-Based Family Intervention : Home-based psychoeducational family intervention jointly conducted by psychology postdoctoral fellow and respiratory therapist over 4 months
21
2: Enhanced Treatment As Usual
Enhanced Treatment As Usual (1 home visit) Project ASPIRE Enhanced Treatment As Usual : Psychoeducational family intervention addressing the written asthma action plan during a single home visit, conducted by a respiratory therapist
20
Total41

Baseline characteristics

Characteristic2: Enhanced Treatment As UsualTotal1: Home-based Family Intervention
Age, Continuous10.6 years
STANDARD_DEVIATION 1.9
10.5 years
STANDARD_DEVIATION 1.6
10.4 years
STANDARD_DEVIATION 1.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
19 Participants40 Participants21 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Sex: Female, Male
Female
9 Participants15 Participants6 Participants
Sex: Female, Male
Male
11 Participants26 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 230 / 20
serious
Total, serious adverse events
0 / 230 / 20

Outcome results

Primary

Asthma Morbidity, as Determined by Number of Asthma Symptom Days, Number of School Days Missed Due to Asthma, and Number of Emergency Department Visits for Acute Asthma

Time frame: 4 months, 10 months

Primary

Mean Score on the Family Asthma Management System Scale (FAMSS)

Family Asthma Management System Scale is semi-structured clinical interview that includes open-ended questions assessing family management of pediatric asthma. The interview is recorded and rated using a standard manual on seven core subscales and two optional subscales.The interview is recorded and rated on seven to nine 9-point subscales that tap the various domains of asthma management, with higher scores indicating better management (1 being the worse asthma management and 9 being the best asthma management). Mean of all of the subscales used to compute a total score.

Time frame: 4 months from baseline

ArmMeasureValue (MEAN)Dispersion
1: Home-based Family InterventionMean Score on the Family Asthma Management System Scale (FAMSS)4.9 units on a scaleStandard Error 0.293
2: Enhanced Treatment As UsualMean Score on the Family Asthma Management System Scale (FAMSS)4.1 units on a scaleStandard Error 0.3
p-value: 0.23Regression, Linear
Primary

Metered Dose Inhaler Checklist (MDIC)

Observational rating scale assessing MDI/spacer technique

Time frame: 4 months, 10 months

Secondary

Brief Symptom Inventory (BSI)

Time frame: 4 months, 10 months

Secondary

Parenting Stress Index - SF (PSI-SF)

Time frame: 4 months, 10 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026